FDA is pushing for safer plastic materials as industry advances toward more efficient uses.
2 reports, 2 independent
Updated Aug 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA is pushing for safer plastic materials as industry advances toward more efficient uses.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- DuPont failed to report health risks from a main ingredient under the Toxic Substances Control Act.Sub-event
FDA and industry are advancing toward safer and more efficient plastic materials.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswireBiopharma Plastic Market Projected to Reach USD 13.35 billion by 2032, Driven by Rising Demand in Automotive Lightweighting | SNS Insider Rising investments in sustainable biopharma plastics, coupled
- PR NewswireDuPont Wins Three 2025 R&D 100 Awards WILMINGTON, Del., Aug. 21, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has won three 2025 R&D 100 Awards in the Mechanical/Materials category.